Connect with us

International

German parliament passes law allowing minors to change their legal gender once a year

Published

6 minute read

Olaf Scholz

From LifeSiteNews

By Andreas Wailzer

“An exception to the unrestricted change of gender entry applies to men if the request for change is obviously in connection with an impending conscription in case of national defense,” the NZZ article states. “In such a case, the gender entry cannot be changed. Men must then remain men.”

The German parliament has passed the so-called “self-identification law,” which allows people confused about their sex, including minors, to change their legal gender once per year.

vote in the Bundestag (German federal parliament) on April 12 saw the law passed as 374 MPs voted in favor, 251 voted against, and eleven MPs abstained.

The new legislation, proposed by Germany’s left-wing government coalition, will allow anyone to change his or her legal gender entry once per year by simply stating their desire to do so to the registry office. Parents can decide to change the legal gender of their children under the age of 14 with their offspring’s “consent.”

Minors between the ages of 14 and 18 can apply to change their gender entry themselves but will need their parents’ consent. However, in the case of a disagreement between parents and their children, a family court can make a decision based on the “best interests of the child.”

Leaked communications of top pro-LGBT doctors have shown that so-called “gender-affirming care” can cause severe mental and physical disease and that it is impossible for minors to give “informed consent” to it.

These doctors “indicate repeatedly that they know that many children and their parents don’t understand the effects that puberty blockers, hormones, and surgeries will have on their bodies,” journalist Michael Shellenberger wrote in his summary of the leaked files. “And yet, they continue to perform and advocate for gender medicine.”

While the “self-identification law” does not include any provisions on medical interventions such as gender surgeries or puberty blockers, a website established by the German government has promoted blockers and hormone injections for gender-confused children.

The head and co-founder of the German pro-family organization DemoFürAlle, Hedwig von Beverfoerde, criticized the new law and pointed out that “socially transitioning” by changing one’s name and legal gender increases the likelihood that minors will go down the path of medical “transition,” even though most children and adolescents grow out of their gender-confusion once they hit adulthood.

“Even if the [German] government claims that the SBGG [self-determination law] has nothing to do with trans-medical measures, this law removes all protective barriers.”

“This is happening at a time when more and more countries are banning the use of puberty blockers, and the evidence from studies is becoming increasingly clear. Most recently, for example, a comprehensive study commissioned by the British Health Service (‘Cass Review’) shows that social transition with name and pronoun changes fuels medical transition and that most young people reconcile with their biological gender if they are given sufficient time to think about it,” she continued.

Von Beverfoerde concluded by calling on the German government to ban puberty blockers, cross-sex hormone injections, and surgical interventions for minors.

READ: UK’s National Health Service to stop prescribing puberty blockers to gender-confused children

Chancellor Olaf Scholz from the Social Democratic Party (SPD) welcomed the law: “We show respect for transgender, intersex and non-binary people – without taking anything away from others.”

“This is how we continue to drive forward the modernization of our country,” he added.

The law was criticized by the politicians from the Christian Democrats (CDU/CSU), the Alternative for Germany (AfD), and the Bünsdnis Sarah Wagenknect (BSW).

AfD MP Martin Reichardt said the law was “ideological nonsense” promoted by “trans-extremists” and that his party rejected the “ludicrous law” in its entirety.

Under the new law, anyone who reveals the former name or true gender of someone who changed their legal registry can be fined up to € 10,000 ($ 10,672) if they share this information “with the intent to harm.”

However, as a report by the newspaper NZZ points out, in the case of war, gender ideology has to take a back seat.

“An exception to the unrestricted change of gender entry applies to men if the request for change is obviously in connection with an impending conscription in case of national defense,” the NZZ article states. “In such a case, the gender entry cannot be changed. Men must then remain men.”

The Self-Determination law is due to come into force on November 1, 2024.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

RFK Jr. planning new restrictions on drug advertising: report

Published on

MXM logo MxM News

Quick Hit:

The Trump administration is reportedly weighing new restrictions on pharmaceutical ads—an effort long backed by Health Secretary Robert F. Kennedy Jr. Proposals include stricter disclosure rules and ending tax breaks.

Key Details:

  • Two key proposals under review: requiring longer side-effect disclosures in TV ads and removing pharma’s tax deduction for ad spending.

  • In 2024, drug companies spent $10.8 billion on direct-to-consumer ads, with AbbVie and Pfizer among the top spenders.

  • RFK Jr. and HHS officials say the goal is to restore “rigorous oversight” over drug promotions, though no final decision has been made.

Diving Deeper:

According to a Bloomberg report, the Trump administration is advancing plans to rein in direct-to-consumer pharmaceutical advertising—a practice legal only in the U.S. and New Zealand. Rather than banning the ads outright, which could lead to lawsuits, officials are eyeing legal and financial hurdles to limit their spread. These include mandating extended disclosures of side effects and ending tax deductions for ad spending—two measures that could severely limit ad volume, especially on TV.

Health and Human Services Secretary Robert F. Kennedy Jr., who has long called for tougher restrictions on drug marketing, is closely aligned with the effort. “We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers,” said HHS spokesman Andrew Nixon in a written statement. Kennedy himself told Sen. Josh Hawley in May that an announcement on tax policy changes could come “within the next few weeks.”

The ad market at stake is enormous. Drugmakers spent $10.8 billion last year promoting treatments directly to consumers, per data from MediaRadar. AbbVie led the pack, shelling out $2 billion—largely to market its anti-inflammatory drugs Skyrizi and Rinvoq, which alone earned the company over $5 billion in Q1 of 2025.

AbbVie’s chief commercial officer Jeff Stewart admitted during a May conference that new restrictions could force the company to “pivot,” possibly by shifting marketing toward disease awareness campaigns or digital platforms.

Pharma’s deep roots in broadcast advertising—making up 59% of its ad spend in 2024—suggest the impact could be dramatic. That shift would mark a reversal of policy changes made in 1997, when the FDA relaxed requirements for side-effect disclosures, opening the floodgates for modern TV drug commercials.

Supporters of stricter oversight argue that U.S. drug consumption is inflated because of these ads, while critics warn of economic consequences. Jim Potter of the Coalition for Healthcare Communication noted that reinstating tougher ad rules could make broadcast placements “impractical.” Harvard professor Meredith Rosenthal agreed, adding that while ads sometimes encourage patients to seek care, they can also push costly brand-name drugs over generics.

Beyond disclosure rules, the administration is considering changes to the tax code—specifically eliminating the industry’s ability to write off advertising as a business expense. This idea was floated during talks over Trump’s original tax reform but was ultimately dropped from the final bill.

Continue Reading

International

Judiciary explores accountability options over Biden decline ‘coverup’

Published on

Former President Joe Biden salutes the departure party before boarding Special Air Mission 46 at Joint Base Andrews, Md., Jan. 20, 2025. 

From The Center Square

By

No obvious solutions emerged during a congressional hearing Wednesday on how to hold those accountable for the alleged cover-up of President Joe Biden’s mental and cognitive decline, but witnesses had some suggestions for how to prevent similar situations in the future.

Republicans have been adamant for some time that Democratic lawmakers, the prior administration, the legacy media and those closest to Biden conspired to hide the former president’s mental and cognitive decline from the American people. More recently, allegations have surfaced that some of Biden’s staff or potentially others may have used an autopen – a machine that can replicate signatures – to sign official documents for Biden without his knowledge or consent.

From the Senate Judiciary Committee hearing on June 18th, 2025

Wednesday’s witnesses agreed that further investigation needs to be done into these questions. Republicans also explored what can be done after the fact and how to prevent similar events from happening in the future. The Senate Judiciary Committee’s hearing into those questions Wednesday’s boycotted by all but one Democrat.

Republicans didn’t miss the opportunity to call them out for it. U.S. Sen. Eric Schmitt, R-MO, said Democrats’ absence and their failure to call any witnesses to testify was “deeply disappointing” but “not surprising.”

“Their absence speaks volumes – an implicit admission that the truth is too inconvenient to face,” Schmitt said. “This de facto boycott is not just a refusal to participate. It’s a refusal to serve the American people who deserve answers about who was truly leading their government.”

From the Senate Judiciary Committee hearing on June 18th, 2025

Much of the hearing’s discussion revolved around proper uses of the autopen, which witnesses testified can only be rightfully used when the president specifically delegates its use to the user. The committee also discussed Section 4 of the 25th Amendment to the Constitution, which talks about succession in the case of a president becoming unfit or unable to fulfill the role. The amendment authorizes the vice president and a majority of the president’s cabinet to declare the president unfit, though that declaration has to be validated by a vote from Congress in order to have any effect.

What’s missing, however, is a clear manner of recourse for lawmakers or the public if those around the president fail to act despite plain signs he is incapable of holding office. Republicans wanted to know what they could do to prevent the alleged conspiracy from simply fading into history without consequences for any involved.

“As a government, it is imperative that we have clear contingency plans when emergency strikes, and yes, it is an emergency when we have a sitting president who is unable to discharge the duties of that office,” said U.S. Sen. John Cornyn, R-TX.

He asked witness Theo Wold, a visiting fellow for law and technology policy with The Heritage Foundation and who worked in the previous Trump administration, if any criminal statutes could be applied to those who are found to have participated in the alleged cover-up.

“In this case, some have suggested that there may be potential crimes committed by members of the Cabinet for failing to act basically, suborning perjury, forging, forging government documents, impersonating a federal officer, making false statements, conspiracy to defraud the United States, obstruction of justice, wire or mail fraud…  Do you think there’s any application of any of those criminal statutes to the circumstances of the Biden presidency?” Cornyn asked.

“There very well could be,” Wold said, but he added that it would be “a question for a prosecutor to take up in their discretion.”

While witnesses agreed that anyone participating in a cover-up should be held accountable, the solutions for doing so weren’t as clear as recommendations for how to prevent similar situations in the future.

John Harrison, James Madison Distinguished Professor of Law at the University of Virginia, didn’t see an obvious method of redress for what already happened but suggested that Congress perhaps require greater documentation of presidential actions going forward.

Wold provided additional suggestions, such as a revival of discussion around “other guardrails” that can be imposed on the 25th Amendment. There was lively debate toward the end of Ronald Reagan’s presidency about adding a mental health professional to the White House medical team or “whether the surgeon general should oversee the inclusion of medical reporting as part of… the 25th Amendment,” according to Wold. But he said there hadn’t been serious discussion since on how to improve the amendment. He also agreed with Sen. Katie Britt, R-AL, that some of the terms in the amendment, like “unable,” should be more clearly defined.

Continue Reading

Trending

X